[1]朱钦辉,陈丹霞,魏统国.替罗非班联合直接取栓对急诊急性脑梗死患者血管再通率影响的临床研究[J].陕西医学杂志,2024,(1):95-98,103.[doi:DOI:10.3969/j.issn.1000-7377.2024.01.021]
 ZHU Qinhui,CHEN Danxia,WEI Tongguo.Effect of direct thrombectomy combined with tirofiban on rate of vascular revascularization in emergency patients with acute cerebral infarction[J].,2024,(1):95-98,103.[doi:DOI:10.3969/j.issn.1000-7377.2024.01.021]
点击复制

替罗非班联合直接取栓对急诊急性脑梗死患者血管再通率影响的临床研究
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年1期
页码:
95-98,103
栏目:
药物与临床
出版日期:
2024-01-31

文章信息/Info

Title:
Effect of direct thrombectomy combined with tirofiban on rate of vascular revascularization in emergency patients with acute cerebral infarction
作者:
朱钦辉陈丹霞魏统国
(梅州市人民医院神经内科,广州 梅州 514000)
Author(s):
ZHU QinhuiCHEN DanxiaWEI Tongguo
(Department of Neurology,Meizhou People's Hospital,Meizhou 514000,China)
关键词:
急性脑梗死 直接取栓 替罗非班 急诊 穿刺成功到再通时间 神经功能
Keywords:
Acute cerebral infarction Direct thrombectomy Tirofiban Emergency Time from successful puncture to recanalization Neural function
分类号:
R 743.3
DOI:
DOI:10.3969/j.issn.1000-7377.2024.01.021
文献标志码:
A
摘要:
目的:本研究旨在探讨直接取栓联合替罗非班对急诊急性脑梗死患者血管再通率的影响。方法:以收治的103例急诊急性脑梗死为研究对象,采用随机数字表法将其分为对照组(给予直接取栓治疗,51例)和研究组(给予直接取栓联合替罗非班治疗,52例)。统计两组患者穿刺成功到再通时间、住院时间及并发症发生情况,对比两组神经功能、再通血流分级及mRS评分。结果:研究组穿刺成功到再通时间及住院时间均少于对照组(均P<0.05)。治疗后,研究组神经功能评分低于对照组(P<0.05),研究组再通血流分级中的3级高于对照组(P<0.05),研究组再通血流率为94.23%(49/52),对照组再通血流率为75.00%(39/52),研究组再通血流率高于对照组(P<0.05)。治疗后,研究组mRS评分低于对照组(P<0.05),研究组并发症发生率低于对照组(P<0.05)。结论: 直接取栓联合替罗非班能够有效提高急诊急性脑梗死患者血管再通率,改善患者预后水平。
Abstract:
Objective:To investigate the effect of direct thrombectomy combined with tirofiban on the rate of vascular revascularization in patients with emergency acute cerebral infarction.Methods:A total of 103 cases of acute cerebral infarction were randomly divided into control group(treated with direct thrombectomy,51 cases)and study group(treated with direct thrombectomy combined with tirofiban,52 cases).The time from successful puncture to recanalization,hospitalization time and complications were recorded.The neurological function,recanalization blood flow grade and mRS score were compared between the two groups.Results:The time from successful puncture to recanalization and hospitalization time in the study group were lower than those in the control group(all P<0.05).After treatment,the neurological function score of the study group was lower than that of the control group(P<0.05).Grade 3 of recanalization blood flow in the study group was higher than that in the control group(P<0.05).The recanalization blood flow rate was 94.23%(49/52)in the study group and 75.00%(39/52)in the control group.The recanalization blood flow rate in study group was higher than that in control group(P<0.05).After treatment,the mRS score of the study group was lower than that of the control group(P<0.05).The complication rate of the study group was lower than that of the control group(P<0.05).Conclusion:Direct thrombectomy combined with tirofiban can effectively improve vascular revascularization rate and improve the prognosis of patients with emergency acute cerebral infarction.

参考文献/References:

[1] 时晋泰,王中琳,吴宣美.中药内服联合针灸推拿对急性脑梗死患者神经功能缺损评分及凝血功能的影响[J].陕西中医,2021,42(12):1783-1785.
[2] 邢惠娟,黄乾坤,马效麟,等.黄角汤治疗脑梗死急性期临床研究[J].陕西中医,2021,42(11):1536-1538,1543.
[3] 薛亚妮,刘瑞,陈彭,等.依达拉奉注射液联合阿替普酶静脉溶栓治疗急性脑梗死临床疗效观察[J].陕西医学杂志,2021,50(6):731-734.
[4] JOVIN T G,NOGUEIRA R G,LANSBERG M G,et al.Thrombectomy for anterior circulation stroke beyond 6h from time last known well(AURORA):A systematic review and individual patientdata meta-analysis[J].Lancet,2022,399(10321):249-258.
[5] TIAN W,ZHANG T,GAO Y,et al.Efficacy and safety assessment ofurokinase plus tirofiban in acute cerebral infarction patients without clearcriminal vessels[J].Pak J Pharm Sci,2022,35(3(Special)):878-883.
[6] ZHANG H,ZHENG L.Statistical analysis for efficacy of tirofiban combinedwith ozagrel in the treatment of progressive cerebral infarction patients out ofthrombolytic therapy time window[J].Clinics(Sao Paulo),2021,14(76):27-28.
[7] 钟迪,张舒婷,吴波.《中国急性缺血性脑卒中诊治指南2018》解读[J].中国现代神经疾病杂志,2019,19(11):897-901.
[8] 张本银,路吾长,杨靖.美国国立卫生研究院卒中量表评分、血浆同型半胱氨酸水平与急性脑梗死的关系及危险因素分析[J].实用临床医药杂志,2021,25(22):102-105.
[9] 康周城,李德帅,李扬,等.急性串联型椎基底动脉闭塞伴对侧椎动脉闭塞或发育不良患者血管内开通策略[J].介入放射学杂志,2023,32(5):464-469.
[10] 陈新华.CT灌注成像对颞浅动脉-大脑中动脉搭桥术后脑血流的评估及与卡氏功能状态评分改良Rankin量表改良Barthel指数的相关性[J].山西医药杂志,2023,52(3):184-187.
[11] EDWARDS M D,HUGHES T A T.Managing blood pressure in acute cerebral infarction[J].J Neurol,2021,268(6):2294-2296.
[12] SHAO Y,ZHANG Y,WU R,et al.Network pharmacology approach to investigate the multitarget mechanisms of Zhishi Rhubarb Soup on acute cerebral infarction[J].Pharm Biol,2022,60(1):1394-1406.
[13] LI C,XU B F,ZHANG M,ET A L.Severe thrombocytopenia with acutecerebral infarction:A case report and literature review[J].Niger J Clin Pract,2023,26(7):1040-1044.
[14] YANG B B,ZOU M,ZHAO L,et al.Astaxanthin attenuates acute cerebralinfarction via Nrf-2/HO-1 pathway in rats[J].Curr Res Transl Med,2021,69(2):103-107.
[15] PODLASEK A,DHILLON P S,BUTT W,et al.Direct mechanicalthrombectomy without intravenous thrombolysis versus bridging therapy for acuteischemic stroke:A meta-analysis of randomized controlled trials[J].Int J Stroke,2021,16(6):621-631.
[16] ZHAO Y,ZHANG Y,YANG Y.Acute cerebral infarction with adenomyosis in apatient with fever:A case report[J].BMC Neurol,2020,20(1):210.
[17] BAIK S H,JUNG C,KIM B M,et al.Mechanical thrombectomy for acute posteriorcerebral artery stroke:Feasibility and predictors of outcome[J].Neuroradiology,2022,64(7):1419-1427.
[18] 张德勤,王邦宁,黎敬锋.美托洛尔缓释片联合替罗非班对老年急性心肌梗死患者PCI术后冠脉血流恢复和心功能的影响[J].中国老年学杂志,2023,43(5):1036-1039.
[19] 李冬梅,陈超,李弘,等.静脉溶栓24 h内使用替罗非班对不稳定穿支动脉梗死的有效性和安全性[J].中国老年学杂志,2023,43(3):520-523.
[20] 彭伟,汪慧,乔向亮.替罗非班可减少脑梗死静脉溶栓后进展性脑梗死的发生率[J].内科急危重症杂志,2023,29(2):137-140.
[21] 贺时磊.小剂量替罗非班在急性脑梗死患者溶栓治疗中的有效性及安全性分析[J].临床研究,2021,29(6):70-72.
[22] 张芬.替罗非班治疗超时间窗急性脑梗死的临床疗效[J].临床合理用药杂志,2021,14(6):61-63.
[23] WANG X F,WANG M,LI G,et al.Efficacy of Solitaire AB stent-release angioplasty in acute middle cerebral arteryatherosclerosis obliterative cerebral infarction[J].World J Clin Cases,2021,9(19):5028-5036.
[24] 司亚克,赵祚翔.替罗非班联合依达拉奉对急性脑梗死患者血小板功能、脑血流量及氧化应激指标的影响[J].海南医学,2021,32(11):1387-1391.
[25] 韩丽丽,项蓉,刘万根,等.Solitaire AB支架取栓术联合替罗非班和丁苯酞对急性脑梗死患者神经功能和炎性因子的影响[J].中国临床研究,2020,33(4):488-492.
[26] 慕鸿泽,吕原峰.神经节苷脂联合羟乙基淀粉对急性脑梗死患者mRS评分和NIHSS评分的影响[J].中国实用医药,2021,16(34):1-4.

相似文献/References:

[1]李福泰,姚春虹△,慕廷民,等.急性脑梗死患者炎症因子与同型半胱氨酸、纤维蛋白原相关性研究*[J].陕西医学杂志,2019,(1):71.
 LI Futai,YAO Chunhong,MU Tingmin,et al.Correlation study between inflammatory factors andhomocysteine and fibrinogen in acute cerebral infarction patients[J].,2019,(1):71.
[2]袁山旗,赵红敏△,张西安,等.机械支架介入取栓联合静脉溶栓治疗老年急性脑梗死临床疗效 及对患者神经功能的影响[J].陕西医学杂志,2019,(2):237.
 YUAN Shanqi,ZHAO Hongmin,ZHANG Xian,et al.Clinical study of mechanical stent intervention and thrombectomy combined with arteriovenous thrombolysis in〖JP〗 the treatment of acute cerebral infarction in the elderly and its effect on neurological function[J].,2019,(1):237.
[3]冯金艳,邱丽华.MRI检查对颈动脉粥样硬化斑块的诊断价值研究*[J].陕西医学杂志,2019,(4):467.
 FENG Jinyan,QIU Lihua..Diagnostic value of MRI examination for carotid atherosclerotic plaques[J].,2019,(1):467.
[4]陆俊杰,张 洋,张清清,等.经微导管注射替罗非班联合Solitaire支架取栓治疗急性脑梗死21例临床研究*[J].陕西医学杂志,2019,(6):740.
[5]廖 涛,刘 超△.触珠蛋白与急性脑梗死患者病情程度及预后相关性分析[J].陕西医学杂志,2020,49(10):1292.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.024]
[6]俞 茜,冯天保,王晓慧,等.磁共振成像平扫、磁敏感加权成像诊断急性脑梗死临床价值对比研究[J].陕西医学杂志,2021,50(4):425.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.010]
[7]包 蕾.阿加曲班联合阿司匹林治疗急性脑梗死疗效及对患者血管内皮功能的影响[J].陕西医学杂志,2021,50(5):603.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.022]
 BAO Lei.Efficacy of agatroban combined with aspirin in treatment of acute cerebral infarction[J].,2021,50(1):603.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.022]
[8]薛亚妮,刘 瑞,陈 彭,等.依达拉奉注射液联合阿替普酶静脉溶栓治疗急性脑梗死临床疗效观察[J].陕西医学杂志,2021,50(6):731.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.023]
[9]王 婷,梁佳佳.不同TOAST分型急性脑梗死患者血清CXC趋化因子配体16、碱性髓鞘蛋白、基质金属蛋白酶-9水平变化及临床意义[J].陕西医学杂志,2021,50(12):1581.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.029]
 WANG Ting,LIANG Jiajia.Changes and clinical significance of serum CXCL16,MBP and MMP-9 levels in patients with different TOAST subtypes of cerebral infarction[J].,2021,50(1):1581.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.029]
[10]姜 飞,王东玉.依达拉奉右莰醇联合尿激酶静脉溶栓治疗急性脑梗死合并糖尿病对患者血清氧化应激水平、颈总动脉内-中膜厚度、血清基质金属蛋白酶-12水平的影响[J].陕西医学杂志,2022,51(1):88.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.023]
 JIANG Fei,WANG Dongyu.Effects of edaravone dexborneol combined with urokinase intravenous thrombolysis on serum oxidative stress,common carotid artery intra-media thickness and serum MMP-12 in patients with acute cerebral infarction and diabetes mellitus[J].,2022,51(1):88.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.023]

备注/Memo

备注/Memo:
基金项目:广东省中医药局科研项目(20222235)
更新日期/Last Update: 2024-01-05